Miralax Orange Flavor Powder, For Solution
Product Images NDC 11523-0122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Miralax Orange Flavor (NDC 11523-0122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Miralax Orange 7 Dose Back Label (Miralax Orange 7 Dose Back Label)

Miralax Orange 7 Dose Back Label (Miralax Orange 7 Dose Back Label)
This text appears to be a drug information label for a product called Miralax. The active ingredient in each dose is Polyethylene Glycol 3350, which is an osmotic laxative used to relieve occasional constipation. The label provides warnings and precautions, including the recommendation to not use if allergic to polyethylene glycol and to consult a doctor before use if experiencing certain symptoms or taking prescription drugs. The directions state the recommended dosage for adults and children, as well as information on how to mix and consume the powder. It also mentions possible side effects and advises to stop use and seek medical assistance if certain symptoms worsen or persist. The label includes information on storage, inactive ingredients, and contact information for questions or comments.*
FDA Label Image

Miralax Orange 7 Dose Front Label (Miralax Orange 7 Dose Front Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.